Skip to main content
Fig. 10 | Journal of Nanobiotechnology

Fig. 10

From: Isolated cell-bound membrane vesicles (CBMVs) as a novel class of drug nanocarriers

Fig. 10

Evaluation of some potential side effects of free doxorubicin (Dox in the graphs) and isolated cell-bound membrane vesicles loaded with doxorubicin (Dox-CBMVs; V-D in the graphs). a The number of white blood cells (WBCs) in blood; b The number of platelets (PLT) in blood; c The concentration of aspartate aminotransferase (AST) in blood; d The concentration of creatine kinase isoenzymes (CK-MB) in blood. * and ** represent p < 0.05 and p < 0.01 compared with the controls, respectively; # represents p < 0.05 compared with the Dox group

Back to article page